Propranolol is NOT an appropriate treatment for vortioxetine-induced restless legs syndrome
Propranolol is not recommended for treating RLS symptoms that developed after starting vortioxetine, as it has no evidence supporting its use for RLS and may actually worsen symptoms. In fact, beta-blockers like propranolol showed a negative association with RLS in systematic studies 1.
Why Propranolol Should Be Avoided
The 2025 American Academy of Sleep Medicine (AASM) guidelines 2 provide comprehensive treatment recommendations for RLS and propranolol is notably absent from all recommendations—it is neither suggested for use nor mentioned as having been studied. This absence is significant given the guideline's thoroughness in evaluating numerous pharmacologic agents.
More importantly, one study found a significant negative association between beta-adrenergic antagonist use and RLS 1, suggesting propranolol could potentially worsen rather than improve symptoms.
The Vortioxetine Context
Interestingly, emerging evidence suggests vortioxetine may actually improve or not worsen RLS symptoms, unlike other antidepressants:
- A 2023 case series reported that 5 of 7 patients experienced regression of RLS symptoms after adding vortioxetine, without needing additional RLS-specific treatment 3
- A 2022 case report documented partial improvement in RLS symptoms with vortioxetine in a patient whose symptoms had worsened with SSRIs 4
- A systematic review found that while many antidepressants can induce or worsen RLS, vortioxetine data suggested it may not aggravate symptoms 5
Recommended Treatment Approach
Instead of propranolol, follow this algorithm:
First-Line Options (Strong Recommendations):
- Gabapentin enacarbil, gabapentin, or pregabalin - These are the strongest recommendations from AASM 2
- IV ferric carboxymaltose - If iron parameters are appropriate (ferritin <75 μg/L or ferritin 75-300 μg/L with transferrin saturation <20%) 2
Second-Line Options (Conditional Recommendations):
- Ferrous sulfate (oral iron) if appropriate iron status 2
- Dipyridamole 2
- Extended-release oxycodone or other opioids 2 - particularly for refractory cases
Critical Consideration:
Before adding any RLS medication, consider whether vortioxetine is actually causing the RLS or potentially helping it. Given the emerging evidence that vortioxetine may improve RLS symptoms 3, 4, the temporal relationship should be carefully evaluated. If symptoms appeared shortly after starting vortioxetine but the patient also has depression/anxiety (which independently increase RLS severity), the vortioxetine may not be the culprit.
What to Avoid:
The AASM specifically recommends against using clonazepam, carbamazepine, valproic acid, and bupropion for RLS 2. Dopamine agonists (pramipexole, ropinirole, rotigotine) are no longer recommended for standard use due to augmentation risk 6.
Common Pitfall
The major pitfall here is assuming that because RLS symptoms appeared after starting vortioxetine, the medication must be causing them. The evidence suggests vortioxetine may be less likely to cause RLS compared to SSRIs and SNRIs 3, 4, 5. Consider checking iron studies first and optimizing iron status before attributing symptoms to vortioxetine or adding additional medications.